Liminal Biosciences Inc (DELISTED) (LMNL:DL)
8.50
0.00 (0.00%)
USD |
NASDAQ |
Sep 26, 16:00
Liminal Biosciences Total Liabilities (Quarterly): 7.790M for June 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 7.790M |
| March 31, 2023 | 7.470M |
| December 31, 2022 | 10.50M |
| September 30, 2022 | 9.868M |
| June 30, 2022 | 41.30M |
| March 31, 2022 | 43.12M |
| December 31, 2021 | 72.29M |
| September 30, 2021 | 78.19M |
| June 30, 2021 | 93.13M |
| March 31, 2021 | 79.15M |
| December 31, 2020 | 80.60M |
| September 30, 2020 | 69.09M |
| June 30, 2020 | 48.00M |
| March 31, 2020 | 44.81M |
| December 31, 2019 | 53.71M |
| September 30, 2019 | 57.18M |
| June 30, 2019 | 54.42M |
| March 31, 2019 | 168.29M |
| December 31, 2018 | 121.91M |
| September 30, 2018 | 156.23M |
| June 30, 2018 | 133.05M |
| March 31, 2018 | 124.56M |
| December 31, 2017 | 111.68M |
| September 30, 2017 | 97.62M |
| June 30, 2017 | 93.95M |
| Date | Value |
|---|---|
| March 31, 2017 | 74.57M |
| December 31, 2016 | 78.58M |
| September 30, 2016 | 70.29M |
| June 30, 2016 | 64.96M |
| March 31, 2016 | 69.10M |
| December 31, 2015 | 50.42M |
| September 30, 2015 | 51.58M |
| June 30, 2015 | 55.86M |
| March 31, 2015 | 79.99M |
| December 31, 2014 | 85.29M |
| September 30, 2014 | 85.61M |
| June 30, 2014 | 68.91M |
| March 31, 2014 | 31.19M |
| December 31, 2013 | 29.33M |
| September 30, 2013 | 25.99M |
| June 30, 2013 | 14.61M |
| March 31, 2013 | 13.69M |
| December 31, 2012 | 17.26M |
| September 30, 2012 | 20.56M |
| June 30, 2012 | 20.78M |
| March 31, 2012 | 19.33M |
| December 31, 2011 | 16.91M |
| September 30, 2011 | 22.36M |
| June 30, 2011 | 22.94M |
| March 31, 2011 | 23.55M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
7.470M
Minimum
Mar 2023
93.13M
Maximum
Jun 2021
50.04M
Average
53.71M
Median
Dec 2019
Total Liabilities (Quarterly) Benchmarks
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 1.987M |
| Lexaria Bioscience Corp | 0.2042M |
| Xenon Pharmaceuticals Inc | 36.88M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 23.99M |
| Shareholders Equity (Quarterly) | 16.20M |
| Current Ratio | 2.775 |